Generic Name: Dronabinol
Form/Strengths: Capsules 2.5 mg, 5 mg, and 10 mg
NDA number: NDA 18-651
US label: Marinol®

Study ID

Study Title

Study Results

Study publications

 S175.2.101 A Double-blind, Randomized, Parallel-group, Pilot Study of Oral Dronabinol versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-related Nausea and Vomiting

Results summary

none available

 S175.3.102 A Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy Study of Oral Dronabinol Alone and in Combination with Ondansetron versus Ondansetron Alone in Subjects with Delayed Chemotherapy-induced Nausea and Vomiting

Results summary

Meiri E, Jhangiani H, Vredenburgh JJ, et al. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Current Medical Research and Opinion, 2007; 23:533-43

Leave a comment

Your email address will not be published. Required fields are marked *